Clinical
decision support system or CDSS is an administrative as well as clinical tool
which helps in improving operational efficiency of healthcare practices. It is
designed to assist physicians & other health professionals in clinical
decision-making tasks. It is an adaptation of decision support system generally
used to aid business management. CDSS deployment helps managing data faster
decision-making, and higher workflow efficiency in patient care.
According
to study, “CDSS
Market: Component (Software), Product (Integrated CDSS), Model (Knowledge-Based
CDSS) Delivery Mode (On-Premise CDSS), Mode of Advice (Active CDSS), Setting
(Inpatient Setting), Type (Therapeutic CDSS), Application (Advanced CDSS) -
Global Forecast Till 2023” the key companies operating in the CDSS
market are Hearst Communications Inc., Wolters Kluwer Health, Oncology
Analytics, Inc., Elsevier B.V., Athenahealth, Inc., Truven Health Analytics,
Agfa-Gevaert Group, Zynx Health, National Decision Support Company, Persivia
Inc., Siemens AG, VisualDx, Epic Systems Corp., Alfa Healthcare, Cerner Corp.,
NextGen Healthcare Information System, Carestream Health Inc., McKesson Corp.,
First Databank, Inc., Wolters Klywer NV, Philips Healthcare, ELSEVIER B.V,
Medical Information Technology Inc., Inferscience, Inc., GE Healthcare,
Allscripts Healthcare Solutions Inc., IBM Corporation. Companies are
implementing the strategy acquisition & collaboration with parallel
companies to expand or strengthen its geographic presence in international
market.
Based
on type, CDSS market is split into diagnostic clinical decision support systems
and therapeutic clinical decision support systems. Based on component type,
market is split into services, hardware and software. Based on product type,
market is split into standalone CDSS, integrated Electronic Health Record (EHR)
with CDSS, integrated Computerized Provider Order Entry (CPOE) with CDSS and
integrated CDSS with CPOE and EHR. Based on model type, market is split into
knowledge-based CDSS and non-knowledge-based CDSS. Based on delivery mode,
market is split into on-premise CDSS and cloud-based CDSS. Based on level of
interactivity, market is split into active CDSS and passive CDSS. Passive CDSS
segment is projected to be the most attractive market owing to advantages such
as saving user’s time, providing valid & reliable information, and
integrating system recommendation alerts. Based on setting, market is segmented
into ambulatory care settings and inpatient settings. In addition, based on
applications, market is segmented into clinical guidelines, drug allergy
alerts, drug-drug interactions, clinical reminders, drug dosing support and
others.
The
CDSS market is driven by growth in incidence of medication errors, followed by
government support & initiatives, rise in prominence and usage of big data
& Mhealth tools, high prevalence of chronic diseases, increase in adoption
of cloud computing in healthcare, high returns on investment for CDSS
solutions, and partnerships between clinical decision support companies and
medical research groups. However, reluctance to adopt mobile CDSS, data
security concerns related to cloud-based CDSS, high investments for IT
infrastructure and lack of interoperability may impact the market. Moreover,
rise in technological advancements in healthcare IT solutions and emerge in
markets for healthcare IT are major opportunities for market.
Based
on geography, the North-American region holds major share in CDSS market owing
to presence of a large number of reimbursement policies, growth in
technologically advanced research & treatment platforms for diagnosis of
chronic diseases, increase in development of IT healthcare organizations and
rise in Canadian healthcare infrastructure in the region. The Asian-Pacific
region is predicted to witness higher growth rate due to increase in the group
medical practices and rapid growth in the geriatric population over the
forecast period.
To
know more, click on the link below:-
Related
Reports:-
Contact
Us:-
Ken
Research
Ankur
Gupta, Head Marketing & Communications
+91-9015378249
No comments:
Post a Comment